Total Payments
$349,162
2024 Payments
$65,625
Companies
38
Transactions
1,570
Medicare Patients
4,115
Medicare Billing
$380,258
Payment Breakdown by Category
Other$269,127 (77.1%)
Travel$32,076 (9.2%)
Food & Beverage$28,544 (8.2%)
Consulting$19,285 (5.5%)
Education$130.08 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $209,427 | 115 | 60.0% |
| Travel and Lodging | $32,076 | 96 | 9.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $31,200 | 17 | 8.9% |
| Food and Beverage | $28,544 | 1,317 | 8.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $28,500 | 12 | 8.2% |
| Consulting Fee | $19,285 | 10 | 5.5% |
| Education | $130.08 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $146,838 | 316 | $0 (2024) |
| Gilead Sciences, Inc. | $70,874 | 129 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $63,765 | 460 | $0 (2024) |
| PFIZER INC. | $19,316 | 62 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $15,312 | 52 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $10,800 | 50 | $0 (2017) |
| Eli Lilly and Company | $5,758 | 7 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $4,848 | 14 | $0 (2024) |
| RedHill Biopharma Inc. | $3,164 | 38 | $0 (2024) |
| Ardelyx, Inc. | $1,455 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65,625 | 206 | ABBVIE INC. ($24,426) |
| 2023 | $36,095 | 193 | ABBVIE INC. ($20,070) |
| 2022 | $42,377 | 185 | ABBVIE INC. ($28,027) |
| 2021 | $23,630 | 170 | Gilead Sciences, Inc. ($8,137) |
| 2020 | $19,312 | 156 | Gilead Sciences, Inc. ($6,871) |
| 2019 | $49,341 | 256 | AbbVie, Inc. ($24,093) |
| 2018 | $56,118 | 210 | AbbVie, Inc. ($19,371) |
| 2017 | $56,665 | 194 | Gilead Sciences Inc ($20,420) |
All Payment Transactions
1,570 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Eli Lilly and Company | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Eli Lilly and Company | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Eli Lilly and Company | OMVOH (Drug) | Travel and Lodging | Cash or cash equivalent | $33.93 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: Immunology | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.47 | General |
| Category: GI | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Immunology | ||||||
| 12/04/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: LIVER DISEASE | ||||||
| 12/03/2024 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Antibiotic | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: GI | ||||||
| 11/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $36.36 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,038 | 2,117 | $450,854 | $100,593 |
| 2022 | 16 | 1,056 | 1,897 | $378,883 | $92,569 |
| 2021 | 18 | 1,261 | 2,252 | $477,977 | $118,677 |
| 2020 | 13 | 760 | 964 | $231,080 | $68,420 |
Total Patients
4,115
Total Services
7,230
Medicare Billing
$380,258
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 102 | 497 | $96,418 | $15,834 | 16.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 96 | 96 | $60,698 | $15,828 | 26.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 164 | 276 | $20,738 | $10,547 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 80 | $8,532 | $6,344 | 74.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 68 | 68 | $41,884 | $5,962 | 14.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 109 | 109 | $14,165 | $5,758 | 40.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 61 | 186 | $28,764 | $5,563 | 19.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 39 | 39 | $29,035 | $5,518 | 19.0% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2023 | 12 | 12 | $9,000 | $5,378 | 59.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 25 | 25 | $20,025 | $5,067 | 25.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 86 | 88 | $6,600 | $4,425 | 67.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 71 | 400 | $61,353 | $4,227 | 6.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 53 | 149 | $22,797 | $3,404 | 14.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $4,190 | $2,533 | 60.5% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 12 | 12 | $9,000 | $2,186 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $1,485 | $1,058 | 71.3% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 16 | 20 | $3,780 | $487.43 | 12.9% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 12 | 12 | $4,800 | $320.40 | 6.7% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $7,590 | $152.46 | 2.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 80 | 80 | $51,066 | $13,601 | 26.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 200 | 306 | $23,064 | $12,573 | 54.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 71 | 317 | $61,498 | $10,782 | 17.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 87 | 88 | $50,875 | $8,538 | 16.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 33 | 33 | $26,433 | $8,120 | 30.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 122 | 128 | $9,600 | $6,480 | 67.5% |
About Dr. Sam Moskowitz, MD
Dr. Sam Moskowitz, MD is a Gastroenterology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851377394.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Moskowitz, MD has received a total of $349,162 in payments from pharmaceutical and medical device companies, with $65,625 received in 2024. These payments were reported across 1,570 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($209,427).
As a Medicare-enrolled provider, Moskowitz has provided services to 4,115 Medicare beneficiaries, totaling 7,230 services with total Medicare billing of $380,258. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Brooklyn, NY
- Active Since 12/16/2005
- Last Updated 06/10/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1851377394
Products in Payments
- Epclusa (Drug) $46,140
- XIFAXAN (Drug) $42,970
- RINVOQ (Biological) $33,513
- Mavyret (Drug) $30,427
- SKYRIZI (Biological) $23,164
- MAVYRET (Drug) $20,462
- VELSIPITY (Drug) $18,545
- Viekira (Drug) $14,149
- PLENVU (Drug) $11,344
- Humira (Biological) $11,242
- TRULANCE (Drug) $10,806
- CLENPIQ (Drug) $9,319
- HUMIRA (Biological) $7,125
- RELISTOR (Drug) $6,373
- PREPOPIK (Drug) $5,974
- Vosevi (Drug) $5,292
- OMVOH (Drug) $4,887
- VOQUEZNA (Drug) $4,848
- Talicia (Drug) $3,038
- APRISO (Drug) $2,239
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Brooklyn
Jianjun Li, M.d, M.D
Gastroenterology — Payments: $307,830
Gastroenterology $307,830
Dr. Nison Badalov, M.d, M.D
Gastroenterology — Payments: $237,374
Gastroenterology $237,374
Smruti Mohanty, Md, Ms, MD, MS
Gastroenterology — Payments: $219,216
Gastroenterology $219,216
Dr. Jonathan Erber, Md, MD
Gastroenterology — Payments: $208,708
Gastroenterology $208,708
Dr. Rabin Rahmani, M.d, M.D
Gastroenterology — Payments: $204,380
Gastroenterology $204,380
Kadirawelpillai Iswara, Md, MD
Gastroenterology — Payments: $191,623
Gastroenterology $191,623